Statement Of Cash Flows [Abstract]

BioArctic - Filing #702565

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-01-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations
140 457 SEK
92 341 SEK
Interest paid, classified as operating activities
984,000 SEK
1 686 SEK
Interest received, classified as operating activities
388,000 SEK
7,000 SEK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
4 386 SEK
12 473 SEK
Other inflows (outflows) of cash, classified as investing activities
27,000 SEK
51,000 SEK
Cash flows from (used in) investing activities
4 412 SEK
12 524 SEK
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
7 389 SEK
6 598 SEK
Dividends paid, classified as financing activities
- SEK
- SEK
Cash flows from (used in) financing activities
7 389 SEK
6 598 SEK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
152 257 SEK
111 463 SEK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
723,000 SEK
1 367 SEK
Cash and cash equivalents
848 405 SEK
999 940 SEK
999 940 SEK
1 112 770 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.